Richard Keh, DPM
Foot Surgery · San Antonio, TXNPI 1386647691
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (53.4%), travel and lodging and education — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Stryker at 53.8% of the total. Reporting peaked in 2019 at $7,439 and has fallen 72.3% since, to $2,059 in 2025. Among foot surgery clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 217 payments — averaging $79.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$9K
- Arthrex$2K
- Imbed Biosciences Inc.$2K
- Mission Medical Distribution, LLC$1K
- Medical Device Business Services, Inc.$853
- Smith+Nephew$545
- plus $2K from 24 others
What the payments were for
- Travel & lodging$6,88940%
- Food & beverage$9,24453%
- Education$1,1827%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 102 | $9,319 |
| Arthrex | 17 | $1,772 |
| Imbed Biosciences Inc. | 14 | $1,577 |
| Mission Medical Distribution, LLC | 6 | $1,250 |
| Medical Device Business Services, Inc. | 5 | $853 |
| Smith+Nephew | 23 | $545 |
| Medinc Of Texas | 2 | $439 |
| Johnson & Johnson | 3 | $166 |
| Kerecis Limited | 8 | $157 |
| Endologix LLC | 1 | $145 |
| Alafair Biosciences, Inc. | 1 | $125 |
| DJO, LLC | 2 | $112 |
| Organogenesis Inc. | 1 | $98 |
| Trilliant Surgical LLC. | 2 | $85 |
| Amgen(2 entities) | 4 | $79 |
| Vertex | 3 | $77 |
| Acera Surgical, Inc. | 2 | $59 |
| Integra Lifesciences Corporation | 3 | $54 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $51 |
| Paratek Pharmaceuticals, Inc. | 3 | $50 |
| Lifenet Health | 1 | $41 |
| Medline Industries LP | 3 | $41 |
| Treace Medical Concepts, Inc. | 2 | $39 |
| Mimedx Group, Inc. | 1 | $37 |
| Acumed LLC | 1 | $34 |
| Triad Life Sciences Inc. | 2 | $32 |
| KCI USA, Inc. | 1 | $23 |
| Avanos Medical | 1 | $21 |
| Averitas Pharma Inc. | 1 | $18 |
| Merck | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VARIAX$2,308
- AXSOS$1,158
- PROstep$943
- ANCHORAGE$772
- SONICANCHOR$754
- MOTOBAND$656
- SMART TOE$606
- ALLOWRAP$507
- AUGMENT INJECTABLE$469
- BIO4$418
- ALLOGRAFT$401
- FIXOS$288
- PROSTEP MICA$160
- HOFFMANN$147
- Torus Stent Graft System$145
- ENDOCROSS Device$145
- PROLAYER$128
- VersaWrap$125
- REGRANEX$122
- Stravix$117
How this compares
$17,315 in reported general payments places this provider in the 90th percentile of 71 foot surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 20 | $19,024 |
| Terbinafine Hcl | 78 | $945 |
| Clotrimazole | 31 | $707 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 14 | $447 |
| Ciclopirox | 12 | $439 |
| Cephalexin | 36 | $200 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 16 | $100 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Ortho Dermatologics, A Division Of Bausch Health US, LLCJublia | $51 | $19,02420 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 71 foot surgery providers in Texas.
Other foot surgery in San Antonio
- Marque AllenSan Antonio$204K
- Lawrence LaverySan Antonio$59K
- Seth AshrafSan Antonio$17K
- Kris FordSan Antonio$15K
- Joshua WardSan Antonio$5K
- Jonathan LorenzanaSan Antonio$4K
- Caroline GaynorSan Antonio$2K
- Jason MirelesSan Antonio$1K
- Marvin SanchezSan Antonio$614
- W Brent GillespieSan Antonio$383
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.